Michael Wulfert

679 total citations
20 papers, 417 citations indexed

About

Michael Wulfert is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Michael Wulfert has authored 20 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Genetics. Recurrent topics in Michael Wulfert's work include Mitochondrial Function and Pathology (8 papers), Acute Myeloid Leukemia Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). Michael Wulfert is often cited by papers focused on Mitochondrial Function and Pathology (8 papers), Acute Myeloid Leukemia Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). Michael Wulfert collaborates with scholars based in Germany, United States and Italy. Michael Wulfert's co-authors include Norbert Gattermann, Detlev Riesner, Ulrich Germing, Rainer Haas, Mark Berneburg, G. Hofhaus, Torsten Haferlach, Verena Schildgen, H. Anne Simmonds and Gerhard Steger and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Michael Wulfert

17 papers receiving 408 citations

Peers

Michael Wulfert

HEMAT

GENET

IMMUN

Elizabeth R. Macari United States

NP Anagnou United States

S. J. Morgan United States

Christine Birdwell United States

Don Lavelle United States

F E Cash United States

Martina Moras France

Yuanxin Ye China

Kristina Vartanian United States

M Misago Japan

Elizabeth R. Macari United States

Michael Wulfert

217 ×0.8

105 ×0.6

HEMAT

174 ×1.5

GENET

18 ×0.4

37 ×0.9

IMMUN

Citations per year, relative to Michael Wulfert Michael Wulfert (= 1×) peers Elizabeth R. Macari

Countries citing papers authored by Michael Wulfert

Since Specialization

Citations

This map shows the geographic impact of Michael Wulfert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wulfert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wulfert more than expected).

Fields of papers citing papers by Michael Wulfert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wulfert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wulfert. The network helps show where Michael Wulfert may publish in the future.

Co-authorship network of co-authors of Michael Wulfert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wulfert. A scholar is included among the top collaborators of Michael Wulfert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wulfert. Michael Wulfert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campillo‐Marcos, Ignacio, Verónica Dávalos, Carlos A. García‐Prieto, et al.. (2024). DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study. British Journal of Haematology. 204(5). 1838–1843. 1 indexed citations

Goel, Manish, et al.. (2021). Using the longest run subsequence problem within homology-based scaffolding. Algorithms for Molecular Biology. 16(1). 11–11. 1 indexed citations

Kuendgen, Andrea, Catharina Müller‐Thomas, Michael Lauseker, et al.. (2018). Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget. 9(45). 27882–27894. 54 indexed citations

Kuendgen, A., Catharina Müller‐Thomas, Michael Lauseker, et al.. (2015). 160 ANALYSIS OF POSSIBLE BIOMARKERS TO PREDICT RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE. Leukemia Research. 39. S82–S82.

Broséus, Julien, Tamara Alpermann, Michael Wulfert, et al.. (2013). Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis. Leukemia. 27(9). 1826–1831. 66 indexed citations

Schildgen, Verena, Michael Wulfert, & Norbert Gattermann. (2011). Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes. Experimental Hematology. 39(6). 666–675.e1. 24 indexed citations

Germing, Ulrich, Judith Neukirchen, Corinna Strupp, et al.. (2011). 57 How to assess the medullary blast count in MDS? Pay attention to the proportion of erythroid cells!. Leukemia Research. 35. S20–S21.

Neumann, Frank, Roland Fenk, Michael Wulfert, et al.. (2008). Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematological Oncology. 26(4). 213–218. 1 indexed citations

Wulfert, Michael, Sylvia S. Bottomley, David Bowen, et al.. (2008). Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes. Experimental Hematology. 36(5). 577–586. 41 indexed citations

10.

Wulfert, Michael, et al.. (2006). Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC. Journal of Chromatography B. 831(1-2). 236–247. 13 indexed citations

11.

Witte, Jürgen, et al.. (2006). Mitochondrial DNA Mutations in Differentiated Thyroid Cancer with Respect to the Age Factor. World Journal of Surgery. 31(1). 51–59. 13 indexed citations

12.

Gattermann, Norbert, et al.. (2005). Severe Impairment of Nucleotide Synthesis Through Inhibition of Mitochondrial Respiration. ChemInform. 36(10).

13.

Gattermann, Norbert, et al.. (2004). Severe Impairment of Nucleotide Synthesis Through Inhibition of Mitochondrial Respiration. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1275–1279. 43 indexed citations

14.

Loh, Mignon L., Simone Martinelli, Viviana Cordeddu, et al.. (2004). Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia Research. 29(4). 459–462. 49 indexed citations

15.

Hofhaus, G., Mark Berneburg, Michael Wulfert, & Norbert Gattermann. (2003). Live Now ‐ Pay by Ageing: High Performance Mitochondrial Activity in Youth and its Age‐Related Side Effects. Experimental Physiology. 88(1). 167–174. 10 indexed citations

16.

Gattermann, Norbert, et al.. (2003). Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood. 103(4). 1499–1502. 29 indexed citations

17.

Wulfert, Michael, et al.. (1999). Detection of point mutations by capillary electrophoresis with temporal temperature gradients. Electrophoresis. 20(14). 2864–2869. 19 indexed citations

18.

Wulfert, Michael, et al.. (1995). Scanning for mutations in the human prion protein open reading frame by temporal temperature gradient gel electrophoresis. Electrophoresis. 16(1). 1851–1860. 8 indexed citations

19.

Riesner, Detlev, et al.. (1993). Prions and nucleic acids: search for "residual" nucleic acids and screening for mutations in the PrP-gene.. PubMed. 80. 173–81. 16 indexed citations

20.

Riesner, Detlev, et al.. (1992). Temperature‐gradient gel electrophoresis for the detection of polymorphic DNA and for quantitative polymerase chain reaction. Electrophoresis. 13(1). 632–636. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact